MA34625B1 - Hydrate de tartrate de 1-((25)-2-amino-4-(2,4-bis(trifluoromethyl)-5,8-dihydropyrido(3,4)pirimidin-7(6h)-yl) - Google Patents
Hydrate de tartrate de 1-((25)-2-amino-4-(2,4-bis(trifluoromethyl)-5,8-dihydropyrido(3,4)pirimidin-7(6h)-yl)Info
- Publication number
- MA34625B1 MA34625B1 MA35861A MA35861A MA34625B1 MA 34625 B1 MA34625 B1 MA 34625B1 MA 35861 A MA35861 A MA 35861A MA 35861 A MA35861 A MA 35861A MA 34625 B1 MA34625 B1 MA 34625B1
- Authority
- MA
- Morocco
- Prior art keywords
- dihydropyrido
- trifluoromethyl
- bis
- amino
- pirimidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
LA PRÉSENTE INVENTION CONCERNE UN HYDRATE 1,5 DE TARTRATE DE 1-{(2S)-2-AMINO-4-[2,4-BIS(TRIFLUOROMÉTHYL)- 5,8-DIHYDROPYRIDO [3,4-D]PYRIMIDIN-7(6H)-YL]-4-OXOBUTYL}- 5,5-DIFLUOROPIPÉRIDIN-2-ONE, UN PROCÉDÉ POUR LE PRÉPARER, ET UNE COMPOSITION PHARMACEUTIQUE POUR INHIBER DPP-IV, QUI COMPREND LEDIT COMPOSÉ COMME COMPOSANT ACTIF.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20100107868 | 2010-11-01 | ||
| PCT/KR2011/008186 WO2012060590A2 (fr) | 2010-11-01 | 2011-10-31 | Hydrate de tartrate de 1-{(2s)-2-amino-4-[2,4-bis(trifluorométhyl)-5,8-dihydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoropipéridin-2-one |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA34625B1 true MA34625B1 (fr) | 2013-10-02 |
Family
ID=45995015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA35861A MA34625B1 (fr) | 2010-11-01 | 2011-10-31 | Hydrate de tartrate de 1-((25)-2-amino-4-(2,4-bis(trifluoromethyl)-5,8-dihydropyrido(3,4)pirimidin-7(6h)-yl) |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8859567B2 (fr) |
| EP (1) | EP2635580B1 (fr) |
| JP (1) | JP6193762B2 (fr) |
| KR (1) | KR101446789B1 (fr) |
| CN (1) | CN103189375B (fr) |
| AP (1) | AP3287A (fr) |
| AR (1) | AR083591A1 (fr) |
| AU (1) | AU2011324253B2 (fr) |
| BR (1) | BR112013010586A2 (fr) |
| CA (1) | CA2814357C (fr) |
| CL (1) | CL2013001137A1 (fr) |
| CO (1) | CO6710945A2 (fr) |
| DO (1) | DOP2013000090A (fr) |
| EA (1) | EA024679B1 (fr) |
| EC (1) | ECSP13012599A (fr) |
| GE (1) | GEP20156218B (fr) |
| IL (1) | IL225808A (fr) |
| MA (1) | MA34625B1 (fr) |
| MX (1) | MX341584B (fr) |
| MY (1) | MY156428A (fr) |
| NZ (1) | NZ609644A (fr) |
| PE (3) | PE20240220A1 (fr) |
| SG (1) | SG189931A1 (fr) |
| TW (1) | TWI519533B (fr) |
| UA (1) | UA106445C2 (fr) |
| UY (1) | UY33696A (fr) |
| WO (1) | WO2012060590A2 (fr) |
| ZA (1) | ZA201302646B (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20080130A1 (es) | 2006-03-31 | 2008-02-25 | Janssen Pharmaceutica Nv | Benzoimidazol-2-il pirimidinas y pirazinas como moduladores del receptor h4 de histamina |
| US9371311B2 (en) | 2008-06-30 | 2016-06-21 | Janssen Pharmaceutica Nv | Benzoimidazol-2-yl pyrimidine derivatives |
| WO2012170702A1 (fr) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulateurs du récepteur gpr119 et traitement de troubles associés à celui-ci |
| DK2964229T3 (da) | 2013-03-06 | 2020-01-27 | Janssen Pharmaceutica Nv | Benzoimidazol-2-yl-pyrimidinmodulatorer af histamin-h4 receptoren |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2490818A1 (fr) * | 2002-07-15 | 2004-01-22 | Merck & Co., Inc. | Inhibiteurs de piperidino pyrimidine dipeptidyl peptidase utilises dans le traitement du diabete |
| AU2004210149A1 (en) * | 2003-01-31 | 2004-08-19 | Merck & Co., Inc. | 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| TWI357902B (en) | 2005-04-01 | 2012-02-11 | Lg Life Science Ltd | Dipeptidyl peptidase-iv inhibiting compounds, meth |
-
2011
- 2011-10-27 TW TW100139075A patent/TWI519533B/zh active
- 2011-10-28 UY UY0001033696A patent/UY33696A/es unknown
- 2011-10-28 AR ARP110103993A patent/AR083591A1/es unknown
- 2011-10-28 KR KR1020110111672A patent/KR101446789B1/ko active IP Right Grant
- 2011-10-31 WO PCT/KR2011/008186 patent/WO2012060590A2/fr active Application Filing
- 2011-10-31 CA CA2814357A patent/CA2814357C/fr active Active
- 2011-10-31 PE PE2023001454A patent/PE20240220A1/es unknown
- 2011-10-31 SG SG2013029434A patent/SG189931A1/en unknown
- 2011-10-31 US US13/879,571 patent/US8859567B2/en active Active
- 2011-10-31 MX MX2013004776A patent/MX341584B/es active IP Right Grant
- 2011-10-31 CN CN201180052217.1A patent/CN103189375B/zh active Active
- 2011-10-31 GE GEAP201113077A patent/GEP20156218B/en unknown
- 2011-10-31 PE PE2018000088A patent/PE20180464A1/es unknown
- 2011-10-31 MY MYPI2013001318A patent/MY156428A/en unknown
- 2011-10-31 UA UAA201305462A patent/UA106445C2/ru unknown
- 2011-10-31 MA MA35861A patent/MA34625B1/fr unknown
- 2011-10-31 NZ NZ609644A patent/NZ609644A/en active IP Right Revival
- 2011-10-31 JP JP2013536534A patent/JP6193762B2/ja active Active
- 2011-10-31 PE PE2013000904A patent/PE20140392A1/es not_active Application Discontinuation
- 2011-10-31 EA EA201390644A patent/EA024679B1/ru unknown
- 2011-10-31 AP AP2013006866A patent/AP3287A/xx active
- 2011-10-31 AU AU2011324253A patent/AU2011324253B2/en active Active
- 2011-10-31 BR BR112013010586A patent/BR112013010586A2/pt not_active Application Discontinuation
- 2011-10-31 EP EP11838195.3A patent/EP2635580B1/fr not_active Revoked
-
2013
- 2013-04-11 ZA ZA2013/02646A patent/ZA201302646B/en unknown
- 2013-04-17 IL IL225808A patent/IL225808A/en active IP Right Grant
- 2013-04-22 DO DO2013000090A patent/DOP2013000090A/es unknown
- 2013-04-25 CL CL2013001137A patent/CL2013001137A1/es unknown
- 2013-04-30 CO CO13108961A patent/CO6710945A2/es unknown
- 2013-05-02 EC ECSP13012599 patent/ECSP13012599A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1154002A1 (en) | Imidazopyridazinecarbonitriles useful as kinase inhibitors | |
| WO2007067506A3 (fr) | Inhibiteurs d'erbb kinase de 2-pyrimidinyl-pyrazolopyridine | |
| SG178591A1 (en) | Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer | |
| WO2006068826A3 (fr) | Inhibiteurs de la kinase erbb a base de 2-pyrimidinyle pyrazolopyridine | |
| WO2008131000A3 (fr) | Inhibiteurs mcl-1 indole 7-substitués | |
| WO2005116028A3 (fr) | Heterocycles bicycliques servant d'inhibiteurs de kinase | |
| EA200970447A1 (ru) | Соединения и композиции в качестве ингибиторов протеинкиназы | |
| MX2013014348A (es) | Compuestos fungicidas de 1-{2-[2-halo-4-(4-halogen-fenoxi)-feni]-2 -alcoxi-2-ciclil-etil}-1h-[1,2,4]triazol sustituidos. | |
| TN2011000245A1 (en) | Organic compounds | |
| WO2012007345A3 (fr) | Imidazo[1,2-a]pyrimidines et -pyridines substitués | |
| UA93424C2 (en) | Preparation of azoxystrobin | |
| TW200800967A (en) | Benzimidazole thiophene compounds | |
| MX2012009074A (es) | Compuestos de urea pirrolo [2, 3-d] pirimidina como inhibidores de janus quinasa. | |
| EA201270590A1 (ru) | Ингибиторы акт | |
| UA106378C2 (ru) | Производные фенилимидазола как ингибиторы фермента pde10a | |
| WO2010091197A3 (fr) | Pastilles destinées à une thérapie combinée | |
| MA34625B1 (fr) | Hydrate de tartrate de 1-((25)-2-amino-4-(2,4-bis(trifluoromethyl)-5,8-dihydropyrido(3,4)pirimidin-7(6h)-yl) | |
| WO2010089327A3 (fr) | Dérivés d'indole en tant qu'agents anti-cancéreux | |
| WO2009097973A3 (fr) | Imidazopyridazines en tant qu'inhibiteurs de par1, leur production et leur utilisation en tant que médicaments | |
| WO2008070354A3 (fr) | Benzidimidazole thiophènes substitués en 5 et 6 pour plk | |
| WO2008086128A3 (fr) | Aminopyrazoles inhibiteurs de kinases | |
| UA92180C2 (en) | Benzimidazole thiophene compounds as plk inhibitors | |
| MY152040A (en) | Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments | |
| WO2007143506A3 (fr) | Composés d'éther benzylique de benzimidazole thiophène substitué non cyclique | |
| TN2013000161A1 (en) | Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate |